The pharmacological effects of Ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine

Psychopharmacology Bulletin

Volumn 34, Issue 3, 1998, Pages 391-397

  Itil, Turan M ^a,b,d   Eralp, Emin ^c   Ahmed, Islah ^b   Kunitz, Aileen ^c   Itil, Kurt Z ^c  

^a NEW YORK UNIVERSITY   (United States)

^b Memory Centers of America   (United States)

^c HZI Research Center Inc   (United States)

^d New York Inst for Medical Research   (United States)

Author keywords

Alzheimer's; Antidementia drugs; Ginkgo biloba; Quantitative pharmaco EEG; Tacrine

Indexed keywords

1 [1 (2 TRIFLUOROMETHYL 4 PYRIMIDINYL) 4 PIPERIDINYLMETHYL] 2 PYRROLIDINONE; DONEPEZIL; GINKGO BILOBA EXTRACT; LISURIDE; NIMODIPINE; OXIRACETAM; PIRACETAM; PRAMIRACETAM; SULOCTIDIL; TACRINE; VINPOCETINE;

ADULT; AGED; ALZHEIMER DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; DATA ANALYSIS; DRUG DETERMINATION; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MEDICAL RECORD; MULTIINFARCT DEMENTIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; DEMENTIA, VASCULAR; ELECTROENCEPHALOGRAPHY; FEMALE; GINKGO BILOBA; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PLANT EXTRACTS; PLANTS, MEDICINAL; TACRINE;

EID: 0031790146     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Federal (German) Legal Gazette, Bundesanzeiger, Nr. 133, July 19, 1994. pp. 7361.
2. Itil, TM. Quantitative EEG changes induced by anticholinergic drugs and their behavioral correlates in man. In: Wortis, J, ed. Recent Advances in Biological Psychiatry. Vol. III. New York: Plenum Press, 1966. pp. 151-173.
3. Itil, TM; Eralp, E; Tsambis, E; Itil, KZ; and Stein, U. Central nervous system effects of Ginkgo biloba, a plant extract. Am. J. Therapeut. (Chapman & Hall) 3:63-73, 1996.
4. Itil, TM, and Martorano, D. Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmacol. Bull. 31:147-158, 1995.
5. Kanowski, S; Herrmann, WM; Stephan, K; Wierich, W; and Horr, R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29:47-56, 1996.
6. Knapp, MJ; Knopman, DS; Solomon, PR; Pendlebury, WW; David, CS; and Gracon, SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271(13):985-991, 1994.
7. Le Bars, PL; Itil, TM; Salzman, C; Saito, A; and Bucci, P. QPEEG for dose-finding of new psychotropics and antidementia drugs. In: Recent Advances in Clinical Neurophysiology. Elsevier Sciences B.V., 1996. pp. 780-783.
8. Le Bars, PL; Katz, M; Berman, N; Itil, TM; Freedman, AM; and Schatzberg, AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278(16):1327-1332, 1997.
9. Minthon, L; Gustafson, L; Dalfelt, G; Hagberg, B; Ilsson, K; Risberg, J; Rosen, I; Selving, B; and Wendt, PE. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG. Dementia (S. Karger AG, Basel, SZ) 4:32-42, 1993.
10. Mohs, RC; Rosen, WG; and Davis, KL. The Alzheimer's Disease Assessment Scale: An instrument for assessing treatment efficacy. Psychopharmacol. Bull. 19:448-450, 1983.